TIMP2 and myocardial infarction: Exosomes derived from TIMP2-overexpressing human umbilical cord mesenchymal stem cells can reduce both myocardial fibrosis and apoptosis of myocytes, and enhance angiogenesis in mice after 30 days post-MI (Ni et al., 2019).